Case Updates
U.S. Chamber submits amicus brief in Delaware Supreme Court arguing that FDA’s marketing authorization pathways entail vastly different risks, costs, and timing for medical device companies, and courts should not imply a contractual term to which a party would not have clearly agreed
February 07, 2025
Jeffrey S. Bucholtz and Kellam M. Conover of King & Spalding LLP, as well as Anthony A. Rickey of Margrave Law LLC, served as outside counsel.